SCHEMBL27810580

SCHEMBL27810580

CC(C)(Cc1cnc(C=O)s1)OC(N)=O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27810521 0.89 BTK (0.36) SMN1; SMN2RECQL
SCHEMBL27788942 0.81 SMN1; SMN2 (0.33) SMN1; SMN2RECQL
SCHEMBL27266929 0.74 MEN1 (0.33) RECQLTSHR
SCHEMBL27726473 0.73 SMN1; SMN2 (0.32) SMN1; SMN2
SCHEMBL27726471 0.71 ADRB2 (0.31) SMN1; SMN2
SCHEMBL28784554 0.70 SMN1; SMN2 (0.38) SMN1; SMN2
SCHEMBL27779427 0.69 MAPK10 (0.34) SMN1; SMN2
SCHEMBL18215491 0.68 — —
SCHEMBL18667339 0.68 — —
SCHEMBL9900646 0.68 L3MBTL1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101808666-A Combination of antimitotic and lasokinase inhibitors as anticancer therapy SCHERING CORP 2010-08-18 — — CN disclosed
Send feedback